We are live on
!
Find out more
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX
Delisted
DBTX was delisted on the 22nd of September, 2023.
39 hedge funds and large institutions have $53.8M invested in Decibel Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
3% less funds holding
Funds holding: 40 → 39 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
34% less capital invested
Capital invested by funds: $81.7M → $53.8M (-$27.9M)
Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
9
Closed
5
Calls
$343K
Puts
–
Net Calls
+$343K
Net Calls Change
-$139K
Top Buyers
| 1 |
BlackRock
New York
|
+$3.07M |
| 2 |
Barclays
London,
United Kingdom
|
+$921K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
+$76.6K |
| 4 |
B
Bailard
Foster City,
California
|
+$75.5K |
| 5 |
Morgan Stanley
New York
|
+$36.7K |
Top Sellers
| 1 |
CC
Casdin Capital
New York
|
-$3.22M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$202K |
| 3 |
Renaissance Technologies
New York
|
-$115K |
| 4 |
Two Sigma Investments
New York
|
-$96K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$86.5K |
